Determination of butyric acid dosage based on clinical and experimental studies – a literature review

Tomasz Banasiewicz; Dorota Domagalska; Katarzyna Borycka-Kiciak; Grażyna Rydzewska

doi:10.5114/pg.2020.95556

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

NOWOŚĆ

Portal dla gastroenterologów!

www.egastroenterologia.pl

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

2/2020
vol. 15

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

streszczenie artykułu:

Artykuł przeglądowy

Determination of butyric acid dosage based on clinical and experimental studies – a literature review

Tomasz Banasiewicz

¹

,

Dorota Domagalska

¹

,

Katarzyna Borycka-Kiciak

²

,

Grażyna Rydzewska

^{3, 4}

Chair and Clinic of General and Endocrine Surgery and of Gastrointestinal Oncology, Poznan University of Medical Sciences, Poznan, Poland

Clinic of General and Colorectal Surgery, Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland

Clinic of Internal Diseases and Gastroenterology, Central Teaching Hospital of the Ministry of Interior and Administration (MSWiA), Warsaw, Poland

Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland

DOI: https://doi.org/10.5114/pg.2020.95556

Data publikacji online: 2020/06/08

Pełna treść artykułu Pobierz cytowanie

Metryki PlumX:

Short-chain fatty acids produced by bacteria living in the large intestine are the main energy substrate for the colonocytes. Butyric acid is used for the treatment and prevention of exacerbations of various gastrointestinal diseases: diarrhoea, intestinal inflammations, functional disorders, dysbiosis, and post-surgery or post-chemotherapy conditions. The current standard doses of butyric acid (150–300 mg) range between 1.5–3% and 15–30% of the reported daily demand. Increased metabolism of the colonocytes in conditions involving intestine damage or inflammation, increased energy expenditure during a disease, stimulation of intestine growth in ‘stress’ conditions with accelerated intestinal passage and increased intestinal excretion, and decreased production of endogenous butyrate due to changes in bacterial flora in different pathological conditions require a significant increase of the supply of this acid. Physiological high demand for butyrate and known mechanisms of pathological conditions indicate that current supplementation doses do not cover the demand and their increase should be considered.

Determination of butyric acid dosage based on clinical and experimental studies – a literature review

Tomasz Banasiewicz 1 , Dorota Domagalska 1 , Katarzyna Borycka-Kiciak 2 , Grażyna Rydzewska 3, 4

Tomasz Banasiewicz

¹

,

Dorota Domagalska

¹

,

Katarzyna Borycka-Kiciak

²

,

Grażyna Rydzewska

^{3, 4}